ARCHIVES

Clinical Trial Pathology Improvements Recommended By Group Remaining Actions After Merit Review

This article is from The Cancer Letter archive.

Vol. 05 No. 02 | January 12, 1979

Download PDF Visit The Full Archive

Related Articles

Interactive RPGs Deadline Is Feb. 20

December 13, 1991

New Treatment Approaches For A Variety Of Leukemias Described At ASH Meeting

January 30, 2004

Therapeutic Vaccine May Fight Pancreatic Cancer

February 23, 2007

Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules

July 30, 1999

CMS Final Rule Imposes 6 Percent Cut On Physician Fees Over Four Years

November 6, 2009

Zofran Label Change Includes Warnings of QT Prolongation

September 30, 2011